Diabetic vitreous hemorrhage secondary to proliferative diabetic retinopathy is a cause of severe vision loss in diabetic patients. Laser photocoagulation remains the primary treatment when the view allows. Intravitreous anti-VEGF injections do not appear to have a role as primary treatment but may have an invaluable role as adjuvant to surgery. Pars plana vitrectomy with endolaser panretinal photocoagulation remains the procedure of choice for non-clearing vitreous hemorrhage.
Fluorescein angiography shows severe ischemia and fluorescein leakage from NVD and NVEs.
Color fundus of photography shows vitreous hemorrhages, retinal hemorrhages, and retinal neovascularization. 
Credit: Dr. Benmoussa N Houda
Benmoussa Ophthalmology Clinic, Constantine, Algeria
Instagram account: @dr.benmoussa_houda
